Form 8-K - Current report:
SEC Accession No. 0001213900-13-003018
Filing Date
2013-06-07
Accepted
2013-06-07 10:57:08
Documents
3
Period of Report
2013-06-07
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT f8k060713_actinium.htm 8-K 22584
2 PRESS RELEASE OF ACTINIUM PHARMACEUTICALS, INC. DATED JUNE 7, 2013. f8k060713ex99i_actinium.htm EX-99.1 12607
3 img.jpg GRAPHIC 15291
  Complete submission text file 0001213900-13-003018.txt   57526
Mailing Address 501 FIFTH AVENUE, 3RD FLOOR NEW YORK NY 10017
Business Address 501 FIFTH AVENUE, 3RD FLOOR NEW YORK NY 10017 212-300-2131
Actinium Pharmaceuticals, Inc. (Filer) CIK: 0001388320 (see all company filings)

EIN.: 880378336 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-52446 | Film No.: 13899335
SIC: 6770 Blank Checks